The mechanism of the angiotensin-converting enzyme inhibitor quinapril is not related to bradykinin level in heart tissue

Peptides

Volumn 23, Issue 6, 2002, Pages 1161-1169

  Barthelemy, Christiane ^a   Eurin, Joelle ^a   Lechat, Philippe ^a   Masson, Francoise ^a   Cortines, Micheline ^a   Mougenot, Nathalie ^a   Soualmia, Hayet ^a   Carayon, Alain ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Angiotensin converting enzyme inhibition; Angiotensins; Bradykinin; Heart; Kidney; Quinapril; Tissue distribution

Indexed keywords

ANGIOTENSIN; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; QUINAPRIL; WATER; ANGIOTENSIN I; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; ISOQUINOLINE DERIVATIVE; TETRAHYDROISOQUINOLINE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEGRADATION; DRUG MECHANISM; HEART; HORMONE DETERMINATION; KIDNEY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RADIOIMMUNOASSAY; RAT; SENSITIVITY AND SPECIFICITY; TIME; TISSUE LEVEL; WATER DEPRIVATION; ANIMAL; BIOSYNTHESIS; BLOOD; HEART MUSCLE; METABOLISM; REPRODUCIBILITY; TISSUE DISTRIBUTION; WISTAR RAT;

ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMAL; BRADYKININ; ISOQUINOLINES; KIDNEY; MALE; MYOCARDIUM; PEPTIDYL-DIPEPTIDASE A; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TISSUE DISTRIBUTION; ANIMALS; TETRAHYDROISOQUINOLINES;

EID: 0035996858     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(02)00050-5     Document Type: Article

References (45)

1. Angiotensin-(1-7) potentiates the coronary vasodilatatory effect of bradykinin in the isolated rat heart
2. Vascular catabolism of bradykinin in the isolated perfused rat kidney
3. Contribution of angiotensin-converting enzyme to the cardiac metabolism of bradykinin: An interspecies study
4. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide
5. Bradykinin peptides in kidney, blood, and other tissues of the rat
6. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides
7. Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme
8. Angiotensin-converting enzyme (ACE) inhibitors and kinin metabolism: Evidence that ACE inhibitors may inhibit a kininase other than ACE
9. Type 2 bradykinin-receptor antagonism does not modify kinin or angiotensin peptide levels
10. Angiotensin-converting enzyme inhibition modifies angiotensin but not kinin peptide levels in human atrial tissue
11. Towards understanding the kallikrein-kinin system: Insights from measurment of kinin peptides
12. Is there an internal cardiac renin-angiotensin system?
13. Development of digoxigenin-labeled peptide: Application to chemiluminoenzyme immunoassay of bradykinin in inflamed tissues
14. 9]BK: Influence of enaprilat
15. Localization and production of angiotensin II in the isolated perfused rat heart
16. Angiotensin II and the heart: On the intracrine renin-angiotensin system
17. Intravascular and interstitial degradation of bradykinin in isolated perfused rat heart
18. Potentiation of the vascular response to kinins by inhibition of myocardial kininases
19. Metabolism of bradykinin by the rat coronary vascular bed
20. Effects of angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptides in rats with myocardial infarction
21. Angiotensin and bradykinin peptides in rats with myocardial infarction
22. Kinins, receptors, kininases and inhibitors - Where did they lead us?
23. Inhibition of angiotensin-converting enzyme (ACE) in plasma and tissue
24. Angiotensin-(1-7): A bioactive fragment of the renin-angiotensin system
25. Antibodies to bradykinin and angiotensin: A use of carbodiimide in immunology
26. Effect of angiotensin-converting-enzyme inhibition on bradykinin metabolism by vascular endothelial cells
27. Comparative studies of tissue inhibition by angiotensin converting enzyme inhibitors
28. Effects of perindoprilat on endothelium-dependent relaxations and contractions in isolated blood vessels
29. Inhibition of aminopeptidase P potentiates wheal response to bradykinin in angiotensin-converting enzyme inhibitor-treated humans
30. Kallidin- and bradykinin-degrading pathways in human heart: Degradation of kallidin by aminopeptidase M-like activity and bradykinin by neutral endopeptidase
31. Contribution of bradykinin to the cardiovascular effects of ramipril
32. Beneficial effects of bradykinin on myocardial energy metabolism and infarct size
33. A local kallikrein-kinin system is present in rat hearts
34. Possible protective effects of kinins and converting enzyme inhibitors in cardiovascular tissues
35. Potentiation of the hypotensive effect of bradykinin by angiotensin-(1-7)-related peptides
36. Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects
37. Neutral endopeptidase in the heart. Neutral endopeptidase inhibition prevents isoproterenol-induced myocardial hypoperfusion in rats by reducing bradykinin degradation
38. Myocardial protection by preconditionning of heart with losartan, an angiotensin II type 1-receptor blocker: Implication of bradykinin dependent and bradykinin independent mechanisms
39. Acute and long-term dose-response study of Quinapril on hormonal profile and tissue angiotensin-converting enzyme in Wistar rats
40. Kinins in the cardiovascular system
41. Evidence for an angiotensin II-like material and for a rapid metabolism angiotensin II in the rat brain
42. Evidence that intrarenal bradykinin plays a role in regulation of renal function
43. Increased bradykinin levels accompany the hemodynamic response to acute inhibition of angiotensin-converting enzyme in dogs with heart failure
44. Bradykinin-dependent cardioprotective effects of losartan against ischemia and reperfusion in rat hearts
45. Atrial natriuretic peptide during water deprivation or hemorrhage in rats. Relationship with arginin vasopressin and osmolarity